ARCT – arcturus therapeutics holdings inc. (US:NASDAQ)
Stock Stats
News
Arcturus Therapeutics (ARCT) had its price target lowered by Citigroup Inc. from $66.00 to $21.00. They now have a "buy" rating on the stock.
Arcturus Therapeutics to Attend Upcoming Investor Conference
Arcturus Therapeutics (ARCT) had its price target raised by Citigroup Inc. from $7.00 to $8.00. They now have a "neutral" rating on the stock.
Arcturus Therapeutics (ARCT) had its price target lowered by Piper Sandler from $72.00 to $25.00. They now have an "overweight" rating on the stock.
Arcturus Therapeutics Holdings Inc (ARCT) Q4 2025 Earnings Call Highlights: Navigating Revenue ... [Yahoo! Finance]
Form 10-K Arcturus Therapeutics For: Dec 31
Form 8-K Arcturus Therapeutics For: Mar 03
Form SCHEDULE 13G/A Arcturus Therapeutics Filed by: BALYASNY ASSET MANAGEMENT L.P.
Form SCHEDULE 13G/A Arcturus Therapeutics Filed by: ARK Investment Management LLC
Form SCHEDULE 13G/A Arcturus Therapeutics Filed by: FEDERATED HERMES, INC.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.